2026 ANCC PMHNP Exam Prep – Psychiatric-Mental
Health Nurse Practitioner Questions, Answers, and
Practice Test Bank Comprehensive Study Guide &
Practice Test Bank | Graded A+
AMERICAN NURSES CREDENTIALING CENTER (ANCC)
Psychiatric-Mental Health Nurse Practitioner (PMHNP-BC) Certification
Complete Exam Preparation | 2025–2026 Edition
Exam Provider: American Nurses Credentialing Center (ANCC)
Exam Code: PMHNP-BC
Total Questions on Actual Exam: 175 (150 scored + 25 pretest)
Time Limit: 3.5 hours
TABLE OF CONTENTS
1. Exam Overview & Blueprint ……………………………………………………………… 3
2. Key Topics & Content Areas ……………………………………………………………… 4
3. Study Strategies & Tips …………………………………………………………………… 6
4. Practice Question Bank …………………………………………………………………… 7
5. Complete Answer Key with Detailed Rationales ……………………………………… 17
6. Key Concepts & Study Keywords ………………………………………………………… 25
,1. EXAM OVERVIEW & BLUEPRINT
What Is the ANCC PMHNP-BC Certification?
The ANCC Psychiatric-Mental Health Nurse Practitioner (PMHNP-BC) certification validates that
a nurse practitioner has the advanced clinical knowledge and skills to provide comprehensive
psychiatric and mental health care across the lifespan.
Exam Structure
| Feature | Detail |
||--|
| Total Questions | 175 (150 scored + 25 pretest/unscored) |
| Time Limit | 3.5 hours |
| Question Types | Multiple choice, select all that apply, ordered response |
| Scoring | Scaled score; passing standard determined by ANCC |
Content Domains & Weighting
| Domain | Focus Area | Approximate Weighting |
|--||-|
| I. Scientific Foundation | Neurobiology, psychopharmacology, genetics, brain anatomy | 22% |
| II. Advanced Practice Skills | Assessment, MSE, screening tools, differential diagnosis | 27% |
| III. Diagnosis & Treatment | Psychiatric disorders across the lifespan, treatment planning | 22%
|
| IV. Psychotherapy | CBT, DBT, ERP, IPT, motivational interviewing | 11% |
| V. Ethical/Legal/Cultural | Informed consent, confidentiality, duty to warn, mandated reporting |
17% |
Key Competencies Assessed
- Psychiatric Assessment – Comprehensive history, mental status exam (MSE), risk assessment
- Differential Diagnosis – DSM-5-TR criteria, ruling out medical causes
- Psychopharmacology – Medication selection, dosing, side effects, drug interactions
- Psychotherapy – Individual, group, and family therapy modalities
- Ethical & Legal – Informed consent, confidentiality, mandated reporting, Tarasoff duty
- Collaborative Care – Interprofessional communication, care coordination
2. KEY TOPICS & CONTENT AREAS
, Domain I: Scientific Foundation (22%)
| Topic | Key Concepts |
|-|--|
| Neurotransmitters | GABA, Glutamate, Serotonin, Dopamine, Norepinephrine |
| Psychopharmacology | SSRIs, SNRIs, MAOIs, Atypical Antipsychotics, Mood Stabilizers |
| CYP450 System | CYP2D6, drug interactions, genetic polymorphisms |
| Brain Anatomy | Amygdala, hippocampus, hypothalamus, prefrontal cortex |
| Neurophysiology | ADHD, PTSD, Schizophrenia, Tourette disorder |
Domain II: Advanced Practice Skills (27%)
| Topic | Key Concepts |
|-|--|
| Mental Status Exam (MSE) | Orientation, attention, memory, insight, judgment |
| Screening Tools | PHQ-9, GAD-7, MoCA, CIWA-Ar, COWS, YMRS |
| Differential Diagnosis | Delirium vs. dementia vs. depression vs. psychosis |
| Risk Assessment | Suicide, violence, decisional capacity |
| Medical Causes | Ruling out secondary causes of psychiatric symptoms |
Domain III: Diagnosis & Treatment (22%)
| Disorder | Key Treatment Concepts |
|-|-|
| Major Depressive Disorder | Treatment-resistant depression, augmentation strategies |
| Bipolar I & II | Acute mania, bipolar depression, maintenance therapy |
| Schizophrenia Spectrum | First vs. second-generation antipsychotics, clozapine REMS |
| Anxiety Disorders | GAD, Panic Disorder, Social Anxiety, PTSD |
| OCD | SSRIs, clomipramine, ERP therapy |
| ADHD | Stimulants, non-stimulants, monitoring |
| Substance Use Disorders | Alcohol, opioids (naltrexone, buprenorphine, disulfiram) |
| Eating Disorders | Binge eating disorder (lisdexamfetamine) |
Domain IV: Psychotherapy (11%)
| Therapy Modality | Primary Indication |
||-|
| Cognitive Behavioral Therapy (CBT) | Depression, anxiety, OCD |
| Dialectical Behavior Therapy (DBT) | Borderline personality disorder |
| Exposure & Response Prevention (ERP) | OCD |
| Prolonged Exposure (PE) / CPT | PTSD |
| Interpersonal Therapy (IPT) | Depression, role transitions |
| Behavioral Activation (BA) | Depression |
Health Nurse Practitioner Questions, Answers, and
Practice Test Bank Comprehensive Study Guide &
Practice Test Bank | Graded A+
AMERICAN NURSES CREDENTIALING CENTER (ANCC)
Psychiatric-Mental Health Nurse Practitioner (PMHNP-BC) Certification
Complete Exam Preparation | 2025–2026 Edition
Exam Provider: American Nurses Credentialing Center (ANCC)
Exam Code: PMHNP-BC
Total Questions on Actual Exam: 175 (150 scored + 25 pretest)
Time Limit: 3.5 hours
TABLE OF CONTENTS
1. Exam Overview & Blueprint ……………………………………………………………… 3
2. Key Topics & Content Areas ……………………………………………………………… 4
3. Study Strategies & Tips …………………………………………………………………… 6
4. Practice Question Bank …………………………………………………………………… 7
5. Complete Answer Key with Detailed Rationales ……………………………………… 17
6. Key Concepts & Study Keywords ………………………………………………………… 25
,1. EXAM OVERVIEW & BLUEPRINT
What Is the ANCC PMHNP-BC Certification?
The ANCC Psychiatric-Mental Health Nurse Practitioner (PMHNP-BC) certification validates that
a nurse practitioner has the advanced clinical knowledge and skills to provide comprehensive
psychiatric and mental health care across the lifespan.
Exam Structure
| Feature | Detail |
||--|
| Total Questions | 175 (150 scored + 25 pretest/unscored) |
| Time Limit | 3.5 hours |
| Question Types | Multiple choice, select all that apply, ordered response |
| Scoring | Scaled score; passing standard determined by ANCC |
Content Domains & Weighting
| Domain | Focus Area | Approximate Weighting |
|--||-|
| I. Scientific Foundation | Neurobiology, psychopharmacology, genetics, brain anatomy | 22% |
| II. Advanced Practice Skills | Assessment, MSE, screening tools, differential diagnosis | 27% |
| III. Diagnosis & Treatment | Psychiatric disorders across the lifespan, treatment planning | 22%
|
| IV. Psychotherapy | CBT, DBT, ERP, IPT, motivational interviewing | 11% |
| V. Ethical/Legal/Cultural | Informed consent, confidentiality, duty to warn, mandated reporting |
17% |
Key Competencies Assessed
- Psychiatric Assessment – Comprehensive history, mental status exam (MSE), risk assessment
- Differential Diagnosis – DSM-5-TR criteria, ruling out medical causes
- Psychopharmacology – Medication selection, dosing, side effects, drug interactions
- Psychotherapy – Individual, group, and family therapy modalities
- Ethical & Legal – Informed consent, confidentiality, mandated reporting, Tarasoff duty
- Collaborative Care – Interprofessional communication, care coordination
2. KEY TOPICS & CONTENT AREAS
, Domain I: Scientific Foundation (22%)
| Topic | Key Concepts |
|-|--|
| Neurotransmitters | GABA, Glutamate, Serotonin, Dopamine, Norepinephrine |
| Psychopharmacology | SSRIs, SNRIs, MAOIs, Atypical Antipsychotics, Mood Stabilizers |
| CYP450 System | CYP2D6, drug interactions, genetic polymorphisms |
| Brain Anatomy | Amygdala, hippocampus, hypothalamus, prefrontal cortex |
| Neurophysiology | ADHD, PTSD, Schizophrenia, Tourette disorder |
Domain II: Advanced Practice Skills (27%)
| Topic | Key Concepts |
|-|--|
| Mental Status Exam (MSE) | Orientation, attention, memory, insight, judgment |
| Screening Tools | PHQ-9, GAD-7, MoCA, CIWA-Ar, COWS, YMRS |
| Differential Diagnosis | Delirium vs. dementia vs. depression vs. psychosis |
| Risk Assessment | Suicide, violence, decisional capacity |
| Medical Causes | Ruling out secondary causes of psychiatric symptoms |
Domain III: Diagnosis & Treatment (22%)
| Disorder | Key Treatment Concepts |
|-|-|
| Major Depressive Disorder | Treatment-resistant depression, augmentation strategies |
| Bipolar I & II | Acute mania, bipolar depression, maintenance therapy |
| Schizophrenia Spectrum | First vs. second-generation antipsychotics, clozapine REMS |
| Anxiety Disorders | GAD, Panic Disorder, Social Anxiety, PTSD |
| OCD | SSRIs, clomipramine, ERP therapy |
| ADHD | Stimulants, non-stimulants, monitoring |
| Substance Use Disorders | Alcohol, opioids (naltrexone, buprenorphine, disulfiram) |
| Eating Disorders | Binge eating disorder (lisdexamfetamine) |
Domain IV: Psychotherapy (11%)
| Therapy Modality | Primary Indication |
||-|
| Cognitive Behavioral Therapy (CBT) | Depression, anxiety, OCD |
| Dialectical Behavior Therapy (DBT) | Borderline personality disorder |
| Exposure & Response Prevention (ERP) | OCD |
| Prolonged Exposure (PE) / CPT | PTSD |
| Interpersonal Therapy (IPT) | Depression, role transitions |
| Behavioral Activation (BA) | Depression |
